NCT07245082

Brief Summary

Diabetes mellitus

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
27mo left

Started Oct 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Oct 2025Aug 2028

Study Start

First participant enrolled

October 9, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 16, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 24, 2025

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 21, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 21, 2028

Last Updated

March 30, 2026

Status Verified

September 1, 2025

Enrollment Period

2.9 years

First QC Date

November 16, 2025

Last Update Submit

March 24, 2026

Conditions

Keywords

ObesityDiabetic macular edemadiabetic kidney diseaseDiabetic retinopathyNutritional statusPhysical activityPeripheral Arterial Occlusive DiseaseBody compositionMetabolic SyndromeDynapenia

Outcome Measures

Primary Outcomes (1)

  • Changes in nutritional status and physical function (including dietary habits, body composition, and grip strength)

    Everytime after physician's appointment(Usually 3 months).

Study Arms (1)

Cohort Study of Patients With Type 2 Diabetes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study will recruit adult participants aged 18 years or older who have been diagnosed with type 2 diabetes mellitus (T2DM), as confirmed by medical history, diagnostic codes, or current use of hypoglycemic medications. Eligible participants must be willing to join the study and provide written informed consent. In addition, they should be able to complete the required baseline assessments, including anthropometric and functional measurements such as height, weight, waist circumference, handgrip strength, and body composition.

You may qualify if:

  • Adults aged 18 or older.
  • Patients diagnosed with type 2 diabetes (based on medical history, diagnostic code, or use of hypoglycemic medication).
  • Participants are willing to participate in the study and have signed the consent form.
  • Participants are able to complete basic assessments (e.g., height, weight, waist circumference, grip strength, body composition, etc.).

You may not qualify if:

  • Individuals who cannot understand the study content.
  • Individuals who cannot cooperate with relevant assessments.
  • Other individuals who are clinically deemed unsuitable for participation by the project leader.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Zhongzheng Dist, 100229, Taiwan

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 2ObesityDiabetic NephropathiesDiabetic RetinopathyMotor ActivityPeripheral Arterial Occlusive Disease 1Metabolic Syndrome

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesDiabetes ComplicationsRetinal DiseasesEye DiseasesDiabetic AngiopathiesVascular DiseasesCardiovascular DiseasesBehaviorInsulin ResistanceHyperinsulinism

Study Officials

  • Chia-Wen Lu, Present Professor

    Department of Family Medicine, National Taiwan University Hospital

    STUDY CHAIR

Central Study Contacts

Chia-Wen Lu, Present Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 16, 2025

First Posted

November 24, 2025

Study Start

October 9, 2025

Primary Completion (Estimated)

August 21, 2028

Study Completion (Estimated)

August 21, 2028

Last Updated

March 30, 2026

Record last verified: 2025-09

Locations